DualEntry | $90,000,000 | (Oct 7, 2025)
Voltai | $1,311,818 | (Oct 7, 2025)
NanoPhoria | $97,716,710 | (Oct 7, 2025)
Ansa Biotechnologies, Inc.
United States
- Emeryville, California
- 07/10/2025
- Series B
- $54,400,000
At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability.
Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.
- Industry Biotechnology Research
- Website https://ansabio.com/
- LinkedIn https://www.linkedin.com/company/ansabio/
Related People
Jason T. GammackFounder
United States -
San Francisco, California
Ansa Biotechnologies specializes in enzymatic DNA synthesis, and as CEO, the focus is on leading the company's strategic initiatives to revolutionize biotech research and development. With over 30 years in life sciences, the work emphasizes M&A, fundraising, and operational leadership to scale innovative solutions effectively.
JTG Investments & Advisory UG enables partnerships with emerging life science companies, providing strategic guidance and financial backing. This dual role demonstrates a commitment to advancing cutting-edge technologies while fostering growth in the biotech ecosystem.
Trogenix | $94,323,600 | (Oct 7, 2025)
SafeHill | $2,600,000 | (Oct 7, 2025)
Moonlake AI | $28,000,000 | (Oct 7, 2025)
Bee Maps (Powered by Hivemapper) | $32,000,000 | (Oct 7, 2025)
Cookiy AI | $7,000,000 | (Oct 7, 2025)
Hupside | $1,700,000 | (Oct 2, 2025)